hD

Income Statement Summary

Bruker (BRKR) annual income statement covering fiscal 2017 through 2022, as reported to the SEC.

  • Bruker reported total revenue of $2.53B in fiscal 2022, up 4.7% from $2.42B in fiscal 2021.
  • Gross profit was $1.31B, up 7.9% from $1.21B. That is a gross margin of 51.6%.
  • Operating income was $432.7M, up 4.7% from $413.3M. Operating margin was 17.1%.
  • Net income was $296.6M, up 7% from $277.1M. Net margin was 11.7%.
  • Diluted earnings per share was $1.99, up 9.9% from $1.81.
  • Total cost of revenue took 48.4% of total revenue, research and development 9.3% and selling, general and administrative 24%.

Total revenue has grown 7.5% a year on average since fiscal 2017, from $1.77B to $2.53B.

An income statement shows what a company sold and what it cost to run the business, ending with the profit left over.

Figures in USD thousands, except per share data
Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17
Total revenue

2,530,700

2,417,900

1,987,500

2,072,600

1,895,600

1,765,900

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Total revenue

2,530,700

2,417,900

1,987,500

2,072,600

1,895,600

1,765,900

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Total cost of revenue

1,225,000

1,208,300

1,047,700

1,077,300

995,600

949,900

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Total cost of revenue

1,225,000

1,208,300

1,047,700

1,077,300

995,600

949,900

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Gross profit

1,305,700

1,209,600

939,800

995,300

900,000

816,000

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Gross profit

1,305,700

1,209,600

939,800

995,300

900,000

816,000

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Operating expenses:
Selling, general and administrative

607,400

561,200

468,600

500,200

444,700

415,200

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Selling, general and administrative

607,400

561,200

468,600

500,200

444,700

415,200

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Research and development

235,900

220,800

198,000

187,700

173,400

161,600

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Research and development

235,900

220,800

198,000

187,700

173,400

161,600

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Other charges (gain), net

29,700

14,300

24,900

6,500

19,500

19,700

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Other charges (gain), net

29,700

14,300

24,900

6,500

19,500

19,700

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Impairment of assets

-

-

-

-

-

-

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Impairment of assets

-

-

-

-

-

-

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Write-off of deferred offering costs

-

-

-

-

-

-

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Write-off of deferred offering costs

-

-

-

-

-

-

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Total operating expenses

873,000

796,300

691,500

694,400

637,600

596,500

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Total operating expenses

873,000

796,300

691,500

694,400

637,600

596,500

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Operating income

432,700

413,300

248,300

300,900

262,400

219,500

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Operating income

432,700

413,300

248,300

300,900

262,400

219,500

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Interest and other income (expense), net

-18,800

-19,700

-22,500

-20,500

-17,700

-21,700

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Interest and other income (expense), net

-18,800

-19,700

-22,500

-20,500

-17,700

-21,700

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Income before income taxes, equity in income of unconsolidated investees, net of tax, and noncontrolling interests in consolidated subsidiaries

413,900

393,600

225,800

280,400

244,700

197,800

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Income before income taxes, equity in income of unconsolidated investees, net of tax, and noncontrolling interests in consolidated subsidiaries

413,900

393,600

225,800

280,400

244,700

197,800

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Income tax provision

116,400

113,000

64,400

82,400

63,700

117,500

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Income tax provision

116,400

113,000

64,400

82,400

63,700

117,500

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Equity in income of unconsolidated investees, net of tax

1,000

-

-

-

-

-

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Equity in income of unconsolidated investees, net of tax

1,000

-

-

-

-

-

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Net income attributable to noncontrolling interests in consolidated subsidiaries

1,900

3,500

3,600

800

1,300

1,700

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Net income attributable to noncontrolling interests in consolidated subsidiaries

1,900

3,500

3,600

800

1,300

1,700

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Net income attributable to Bruker Corporation

296,600

277,100

157,800

197,200

179,700

78,600

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Net income attributable to Bruker Corporation

296,600

277,100

157,800

197,200

179,700

78,600

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Net income per common share attributable to Bruker Corporation shareholders:
Basic

2.00

1.83

1.03

1.27

1.15

0.50

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Basic

2.00

1.83

1.03

1.27

1.15

0.50

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Diluted

1.99

1.81

1.02

1.26

1.14

0.49

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Diluted

1.99

1.81

1.02

1.26

1.14

0.49

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Weighted average common shares outstanding:
Basic

0

0

0

0

156,200

158,100

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Basic

0

0

0

0

156,200

158,100

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Diluted

0

0

0

0

157,200

159,100

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Diluted

0

0

0

0

157,200

159,100

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Consolidated net income

298,500

280,600

161,400

198,000

181,000

80,300

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Consolidated net income

298,500

280,600

161,400

198,000

181,000

80,300

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Foreign currency translation adjustments (net of tax of $1.4, $2.1 million and $1.2, respectively)

-67,400

-77,800

97,400

-4,300

-25,500

97,100

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Foreign currency translation adjustments (net of tax of $1.4, $2.1 million and $1.2, respectively)

-67,400

-77,800

97,400

-4,300

-25,500

97,100

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Derivatives designated as hedging instruments (net of tax of ($13.8) , $12.5 , respectively)

44,200

51,400

-75,800

-15,700

-

-

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Derivatives designated as hedging instruments (net of tax of ($13.8) , $12.5 , respectively)

44,200

51,400

-75,800

-15,700

-

-

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Changes in hedging instruments

-

-

-

-

-

-

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Changes in hedging instruments

-

-

-

-

-

-

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Pension liability adjustments (net of tax of ($11.8) , ($3.9) and ($1.7) , respectively)

-45,000

-14,500

-7,500

23,000

-15,300

-6,500

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Pension liability adjustments (net of tax of ($11.8) , ($3.9) and ($1.7) , respectively)

-45,000

-14,500

-7,500

23,000

-15,300

-6,500

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Comprehensive income

320,300

268,700

190,500

155,000

170,800

183,900

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Comprehensive income

320,300

268,700

190,500

155,000

170,800

183,900

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Less: Comprehensive income (loss) attributable to noncontrolling interests

1,600

1,000

4,000

1,800

1,300

-

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Less: Comprehensive income (loss) attributable to noncontrolling interests

1,600

1,000

4,000

1,800

1,300

-

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Less: Comprehensive income (loss) attributable to noncontrolling interests

-900

-100

-500

-1,500

-200

2,400

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Less: Comprehensive income (loss) attributable to noncontrolling interests

-900

-100

-500

-1,500

-200

2,400

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Comprehensive income attributable to Bruker Corporation

319,600

267,800

187,000

154,700

169,700

181,500

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Comprehensive income attributable to Bruker Corporation

319,600

267,800

187,000

154,700

169,700

181,500

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Dividend declared per common share (in dollars per share)

-

-

-

-

-

-

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Dividend declared per common share (in dollars per share)

-

-

-

-

-

-

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Product
Total revenue

2,109,900

2,017,300

1,638,100

1,744,700

1,576,600

1,479,500

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Total revenue

2,109,900

2,017,300

1,638,100

1,744,700

1,576,600

1,479,500

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Total cost of revenue

984,000

979,300

840,200

878,500

801,100

787,700

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Total cost of revenue

984,000

979,300

840,200

878,500

801,100

787,700

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Service
Total revenue

414,600

393,200

343,400

322,400

311,700

278,200

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Total revenue

414,600

393,200

343,400

322,400

311,700

278,200

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Total cost of revenue

240,800

228,200

206,500

198,300

193,400

160,800

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Total cost of revenue

240,800

228,200

206,500

198,300

193,400

160,800

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Other
Total revenue

6,200

7,400

6,000

5,500

7,300

8,200

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Total revenue

6,200

7,400

6,000

5,500

7,300

8,200

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Total cost of revenue

200

800

1,000

500

1,100

1,400

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Total cost of revenue

200

800

1,000

500

1,100

1,400

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx